Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which
accelerates system-on-chip (SoC) creation, today announced
financial results for the fourth quarter and year ended
December 31, 2023 and provided first quarter and full year
2024 guidance.
"We're excited to report a strong finish to
2023, with Annual Contract Value and Trailing-Twelve-Month Variable
Royalties of $56.1 million, above the high end of our guidance
range," said K. Charles Janac, President and CEO of Arteris. "We
believe that the accelerating adoption of commercial System IP
solutions across the industry’s most complex applications including
Generative AI and advanced mobility is becoming clear. With 23 net
new Active Customers in 2023, including several of the world’s
largest electronics companies, as well as a record number of
license deals and customer chip designs, the scale and scope of our
long-term opportunity remains robust," concluded Janac.
Fourth Quarter 2023 Financial
Highlights:
- Revenue of $12.5
million, up 12% year-over-year
- Annual Contract
Value (ACV) and trailing twelve months (TTM) variable royalties of
$56.1 million, up 7% year-over-year
- Remaining performance obligation
(RPO) of $72.7 million, up 26% year-over-year
- Operating loss of
$9.2 million
- Non-GAAP operating
loss of $5.5 million, compared to a Non-GAAP operating loss of
$5.8 million in the year-ago period
- Net loss of
$10.5 million or $0.29 per share
- Non-GAAP net loss
of $6.8 million or $0.18 per share
- Non-GAAP free cash
flow of $(3.4) million or (27)% of revenue
Full year 2023 Financial
Highlights:
- Revenue of
$53.7 million, up 7% year-over-year
- Operating loss of
$35.1 million
- Non-GAAP operating
loss of $19.8 million, compared to a Non-GAAP operating loss
of $16.2 million for the year-ended 2022
- Net loss of
$36.9 million or $1.03 per share
- Non-GAAP net loss
of $21.6 million or $0.60 per share
- Non-GAAP free cash
flow of $(17.2) million or (32)% of revenue
Fourth Quarter 2023 Business
Highlights:
- Highest level of
quarterly design activity for the company, with 29 confirmed design
starts across all our verticals. This includes another nine
artificial intelligence/machine learning (AI/ML) designs for the
quarter and 37 for 2023;
- Added four Active
Customers in the quarter, for a total of 23 net new Active
Customers in 2023;
- 65% year-over-year
increase in trailing-twelve-months variable royalties and other
revenue;
- Rain AI selected
FlexNoC 5 interconnect for its family of AI accelerator products,
optimized for high-performance, low-power Generative AI and Edge AI
computing;
- Scalinx licensed Ncore
and FlexNoC interconnect IP for its next-generation Modem SoC
dedicated to wireless communication infrastructure, delivering
ultra-high capacity, multi-gigabit links over long distances;
- Partnered with
Semidynamics, a provider of fully customizable high-performance
RISC-V processor IP, enabling an acceleration of product innovation
for AI/ML and high-performance computing applications;
- Ncore cache coherent
interconnect IP achieved ISO 26262 up to ASIL D, the most stringent
level of functional safety for automotive technology;
- Awarded ISO 9001:2015
certification for Quality Management Systems, validating Arteris’
capabilities to consistently design, develop, and deploy
high-quality products and services; and
- FlexNoC 5 continues
its momentum with 12 additional customers having licensed and/or
upgraded in the quarter.
Non-GAAP gross profit, Non-GAAP gross margin,
Non-GAAP operating loss, Non-GAAP operating loss margin, Non-GAAP
net loss, Non-GAAP net loss per share, free cash flow and free cash
flow margin are Non-GAAP financial measures. Additional information
on Arteris’ historic reported results, including a reconciliation
of these Non-GAAP financial measures to their most comparable GAAP
measures, is included in the financial tables below.
First Quarter and Full Year 2024
Guidance:
|
Q1 2024 |
FY 2024 |
|
(in millions, except %) |
ACV + TTM royalties |
$55.0 - $59.0 |
$62.0 - $68.0 |
Revenue |
$12.1 - $13.1 |
$54.5 - $57.5 |
Non-GAAP operating loss (%) |
40.8% - 60.8% |
33.2% - 43.2% |
Free cash flow (%) |
(9.2)% - 10.8% |
(4.8)% - 5.2% |
|
|
|
The guidance provided above are forward-looking
statements and reflects Arteris' expectations as of today's date.
Actual results may differ materially. Refer to the section titled
"Forward-Looking Statements" below for information on the factors,
among others, that could cause our actual results to differ
materially from these forward-looking statements.
A reconciliation of Non-GAAP guidance measures
reported above to corresponding GAAP measures is not available on a
forward-looking basis without unreasonable effort due to the
uncertainty of expenses that may be incurred in the future,
although it is important to note that these factors could be
material to Arteris' results computed in accordance with GAAP.
Definitions of the other business metrics used
in this press release including ACV, active customers, confirmed
design starts and RPO are included below under the heading “Other
Business Metrics.”
Conference Call
Arteris will host a conference call today on
February 20, 2024 to review its fourth quarter and full year 2023
financial results and to discuss its financial outlook.
|
Time: |
4:30 PM ET |
|
|
United States/Canada Toll Free: |
1-888-886-7786 |
|
|
International Toll: |
1-416-764-8658 |
|
|
|
|
|
A live webcast will also be available in the
Investor Relations section of Arteris’ website at:
https://ir.arteris.com/events-and-presentations
A replay of the webcast will be available in the
Investor Relations section of Arteris' website approximately two
hours after the conclusion of the call and remain available for
approximately 30 calendar days.
About Arteris
Arteris is a leading provider of system IP for
the acceleration of system-on-chip (SoC) development across today’s
electronic systems. Arteris network-on-chip (NoC) interconnect IP
and SoC integration automation technology enable higher product
performance with lower power consumption and faster time to market,
delivering better SoC economics so its customers can focus on
dreaming up what comes next. Learn more at arteris.com.
© 2004-2024 Arteris, Inc. All rights reserved
worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other
Arteris marks found at https://www.arteris.com/trademarks are
trademarks or registered trademarks of Arteris, Inc. or its
subsidiaries. All other trademarks are the property of their
respective owners.
Investor Contacts:ArterisNick
HawkinsChief Financial OfficerIR@arteris.com
Sapphire Investor Relations, LLCErica Mannion and
Michael Funari+1 617 542 6180IR@arteris.com
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995, as amended, including but not limited to,
statements regarding our future financial and operating
performance, including our GAAP and Non-GAAP guidance for the
fourth quarter and full year 2023 and first quarter and full year
2024; our market opportunity and its potential growth; and our
position within the market and our ability to drive customer value.
The words "may," "might," "will," "could," "would," "should,"
"expect," "plan," "anticipate," "intend," "believe," "expect,"
"estimate," "seek," "predict," "future," "project," "potential,"
"continue," "target" and similar words or expressions are intended
to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. Any
forward-looking statements contained herein are based on our
historical performance and our current plans, estimates and
expectations and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent our expectations as of the date of this press
release. Subsequent events may cause these expectations to change,
and we disclaim any obligation to update the forward-looking
statements in the future, except as required by law. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially from our current expectations. Important factors that
could cause actual results to differ materially from those
anticipated in our forward-looking statements include, but are not
limited to, the significant competition we face from larger
companies and third-party providers; our history of net losses;
whether semiconductor companies in the automotive market,
enterprise computing market, communications market, consumer
electronics market, and industrial markets incorporate our
solutions into their end products and the growth and economic
stability of these end markets; our ability to attract new
customers and the extent to which our customers renew their
subscriptions for our solutions; the ability of our customers’ end
products achieving market acceptance or growth; our ability to
sustain or grow our licensing revenue; our ability, and the cost,
to successfully execute on research and development efforts; the
occurrence of product errors or defects in our solutions; if we
fail to offer high-quality support; the occurrence of
macro-economic conditions that adversely impact us, our customers
and their end product markets; the effects of geopolitical
conflicts, such as the military conflict between Russia and
Ukraine; the range of regulatory, operational, financial and
political risks we are exposed to as a result of our dependence on
international customers and operations; our ability to protect our
proprietary technology and inventions through patents and other IP
rights; whether we are subject to any liabilities or fines as a
result of government regulation, including import, export and
economic sanctions laws and regulations; the occurrence of a
disruption in our networks or a security breach; risks associated
with doing business in China; and the other factors described under
the heading “Risk Factors” in our Annual Report on Form 10-K for
the year ended December 31, 2023 to be filed with the Securities
and Exchange Commission (SEC) on or about February 20, 2024. All
forward-looking statements reflect our beliefs and assumptions only
as of the date of this press release. We undertake no obligation to
update forward-looking statements to reflect future events or
circumstances. Our results for the quarter and year ended December
31, 2023 are not necessarily indicative of our operating results
for any future periods.
Arteris, IncCondensed Consolidated
Statements of Loss(In thousands, except share and per
share data)(Unaudited) |
|
|
Three Months Ended December 31, |
|
Twelve Months Ended December 31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Revenue |
|
|
|
|
|
|
|
Licensing, support and maintenance |
$ |
11,347 |
|
|
$ |
10,269 |
|
|
$ |
48,273 |
|
|
$ |
46,012 |
|
Variable royalties and other |
|
1,157 |
|
|
|
934 |
|
|
|
5,393 |
|
|
|
4,366 |
|
Total revenue |
|
12,504 |
|
|
|
11,203 |
|
|
|
53,666 |
|
|
|
50,378 |
|
Cost of revenue |
|
1,448 |
|
|
|
1,085 |
|
|
|
5,077 |
|
|
|
4,281 |
|
Gross profit |
|
11,056 |
|
|
|
10,118 |
|
|
|
48,589 |
|
|
|
46,097 |
|
Operating expense: |
|
|
|
|
|
|
|
Research and development |
|
10,663 |
|
|
|
10,318 |
|
|
|
45,128 |
|
|
|
41,167 |
|
Sales and marketing |
|
5,029 |
|
|
|
4,631 |
|
|
|
20,659 |
|
|
|
17,419 |
|
General and administrative |
|
4,613 |
|
|
|
4,229 |
|
|
|
17,944 |
|
|
|
16,367 |
|
Total operating expenses |
|
20,305 |
|
|
|
19,178 |
|
|
|
83,731 |
|
|
|
74,953 |
|
Loss from operations |
|
(9,249 |
) |
|
|
(9,060 |
) |
|
|
(35,142 |
) |
|
|
(28,856 |
) |
Interest expense |
|
(75 |
) |
|
|
(29 |
) |
|
|
(211 |
) |
|
|
(89 |
) |
Other income (expense), net |
|
917 |
|
|
|
1,019 |
|
|
|
3,558 |
|
|
|
1,425 |
|
Loss before income taxes and loss from equity method
investment |
|
(8,407 |
) |
|
|
(8,070 |
) |
|
|
(31,795 |
) |
|
|
(27,520 |
) |
Loss from equity method investment, net of tax |
|
910 |
|
|
|
284 |
|
|
|
3,397 |
|
|
|
284 |
|
Provision for (benefit from) income taxes |
|
1,224 |
|
|
|
(1,139 |
) |
|
|
1,677 |
|
|
|
(417 |
) |
Net loss |
$ |
(10,541 |
) |
|
$ |
(7,215 |
) |
|
$ |
(36,869 |
) |
|
$ |
(27,387 |
) |
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders, basic and
diluted |
$ |
(0.29 |
) |
|
$ |
(0.21 |
) |
|
$ |
(1.03 |
) |
|
$ |
(0.84 |
) |
Weighted average shares used on computing per share amounts, basic
and diluted |
|
36,816,597 |
|
|
|
33,596,146 |
|
|
|
35,675,689 |
|
|
|
32,578,776 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arteris, Inc.Condensed Consolidated
Balance Sheets(In thousands, except share and per share
data) |
|
|
As of December 31, |
|
|
2023 |
|
|
|
2022 |
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
13,696 |
|
|
$ |
37,423 |
|
Short-term investments |
|
27,477 |
|
|
|
30,728 |
|
Accounts receivable, net of allowance of $93 and $250 as of
December 31, 2023 and 2022, respectively |
|
12,003 |
|
|
|
7,143 |
|
Prepaid expenses and other current assets |
|
5,254 |
|
|
|
5,818 |
|
Total current assets |
|
58,430 |
|
|
|
81,112 |
|
Property and equipment, net |
|
5,745 |
|
|
|
3,617 |
|
Long-term investments |
|
11,802 |
|
|
|
4,427 |
|
Equity method investment |
|
8,500 |
|
|
|
11,897 |
|
Operating lease right-of-use assets |
|
4,289 |
|
|
|
1,883 |
|
Intangibles, net |
|
3,858 |
|
|
|
4,575 |
|
Goodwill |
|
4,178 |
|
|
|
4,218 |
|
Other assets |
|
5,999 |
|
|
|
3,787 |
|
TOTAL ASSETS |
$ |
102,801 |
|
|
$ |
115,516 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ |
183 |
|
|
$ |
572 |
|
Accrued expenses and other current liabilities |
|
11,831 |
|
|
|
12,095 |
|
Operating lease liabilities, current |
|
781 |
|
|
|
899 |
|
Deferred revenue, current |
|
31,537 |
|
|
|
28,839 |
|
Vendor financing arrangements, current |
|
2,070 |
|
|
|
1,264 |
|
Total current liabilities |
|
46,402 |
|
|
|
43,669 |
|
Deferred revenue, noncurrent |
|
25,172 |
|
|
|
21,840 |
|
Operating lease liabilities, noncurrent |
|
3,610 |
|
|
|
1,009 |
|
Vendor financing arrangements, noncurrent |
|
1,292 |
|
|
|
448 |
|
Deferred income, noncurrent |
|
8,810 |
|
|
|
9,993 |
|
Other liabilities |
|
2,412 |
|
|
|
1,022 |
|
Total liabilities |
|
87,698 |
|
|
|
77,981 |
|
Commitments and contingencies |
|
|
|
Stockholders’ equity: |
|
|
|
Preferred stock, par value of $0.001—10,000,000 shares authorized
and no shares issued and outstanding as of both December 31,
2023 and 2022 |
|
— |
|
|
|
— |
|
Common stock, par value of $0.001—300,000,000 shares authorized at
December 31, 2023 and 2022; 37,518,583 and 34,625,875 shares
issued and outstanding at December 31, 2023 and 2022,
respectively |
|
37 |
|
|
|
34 |
|
Additional paid-in capital |
|
118,193 |
|
|
|
103,778 |
|
Accumulated other comprehensive income |
|
120 |
|
|
|
101 |
|
Accumulated deficit |
|
(103,247 |
) |
|
|
(66,378 |
) |
Total stockholders’ equity |
|
15,103 |
|
|
|
37,535 |
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ |
102,801 |
|
|
$ |
115,516 |
|
|
Arteris, Inc.Condensed Consolidated
Statements of Cash Flows(In thousands) |
|
|
Twelve Months Ended December 31, |
|
|
2023 |
|
|
|
2022 |
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
Net loss |
$ |
(36,869 |
) |
|
$ |
(27,387 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities: |
|
|
|
Depreciation and amortization |
|
3,069 |
|
|
|
2,099 |
|
Stock-based compensation |
|
14,535 |
|
|
|
11,692 |
|
Pension plan expenses |
|
134 |
|
|
|
136 |
|
Non-cash operating lease expense |
|
118 |
|
|
|
(21 |
) |
Amortization of deferred income |
|
(1,179 |
) |
|
|
(391 |
) |
Gain on deconsolidation of subsidiary |
|
— |
|
|
|
(149 |
) |
Loss from equity method investment |
|
3,397 |
|
|
|
284 |
|
Net accretion of discounts on available-for-sale securities |
|
(893 |
) |
|
|
(177 |
) |
Deferred income taxes |
|
— |
|
|
|
(484 |
) |
Other, net |
|
10 |
|
|
|
14 |
|
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable, net |
|
(4,858 |
) |
|
|
7,102 |
|
Prepaid expenses and other assets |
|
(1,301 |
) |
|
|
202 |
|
Accounts payable |
|
(389 |
) |
|
|
(1,034 |
) |
Accrued expenses and other liabilities |
|
2,467 |
|
|
|
517 |
|
Deferred revenue |
|
6,030 |
|
|
|
830 |
|
Net cash used in operating activities |
|
(15,729 |
) |
|
|
(6,767 |
) |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
Purchases of property and equipment |
|
(1,503 |
) |
|
|
(1,051 |
) |
Purchases of available-for-sale securities and other |
|
(47,788 |
) |
|
|
(35,031 |
) |
Proceeds from maturities of available-for-sale securities |
|
44,650 |
|
|
|
— |
|
Payments relating to investment in equity method investment |
|
— |
|
|
|
(519 |
) |
Proceeds from principal portion of related party loan |
|
— |
|
|
|
241 |
|
Payments for business combination, net of cash acquired |
|
— |
|
|
|
(1,121 |
) |
Other |
|
(50 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(4,691 |
) |
|
|
(37,481 |
) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
Payments of contingent consideration for business combination |
|
(1,592 |
) |
|
|
(1,573 |
) |
Payments to tax authorities for shares withheld from employees |
|
(607 |
) |
|
|
(2,065 |
) |
Principal payments under vendor financing arrangements |
|
(1,289 |
) |
|
|
(1,136 |
) |
Proceeds from exercise of stock options |
|
490 |
|
|
|
876 |
|
Payments of deferred offering costs |
|
— |
|
|
|
(256 |
) |
Other |
|
79 |
|
|
|
— |
|
Net cash used in financing activities |
|
(2,919 |
) |
|
|
(4,154 |
) |
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
|
(23,339 |
) |
|
|
(48,402 |
) |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of
period |
|
37,423 |
|
|
|
85,825 |
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period |
$ |
14,084 |
|
|
$ |
37,423 |
|
|
Non-GAAP Financial Measures
To supplement our financial results, which are
prepared and presented in accordance with GAAP, we use certain
non-GAAP financial measures, as described below, to understand and
evaluate our core performance. These non-GAAP measures, which may
be different than similarly-titled measures used by other
companies, are presented to enhance investors’ overall
understanding of our financial performance and should not be
considered a substitute for, or superior to, the financial
information prepared and presented in accordance with GAAP.
We define "Non-GAAP gross profit and Non-GAAP
gross margin" as GAAP gross profit and GAAP gross margin, adjusted
for stock-based compensation expense included in cost of revenue.
We define “Non-GAAP Loss from Operations” as our income (loss) from
operations adjusted to exclude stock-based compensation,
acquisition costs and amortization of acquired intangible assets.
We define “Non-GAAP Net Loss” as our net income (loss) adjusted to
exclude stock-based compensation, acquisition costs, amortization
of acquired intangible assets and gain on extinguishment of
debt.
We define “Non-GAAP EPS”, as our Non-GAAP Net
Income (Loss) divided by our GAAP weighted-average number of shares
outstanding for the period on a diluted basis. Management uses
Non-GAAP EPS to evaluate the performance of our business on a
comparable basis from period to period.
The above items are excluded from our Non-GAAP
Gross Profit, Non-GAAP Income (Loss) from Operations and Non-GAAP
Net Income (Loss) because these items are non-cash in nature, or
are not indicative of our core operating performance, and render
comparisons with prior periods and competitors less meaningful. We
believe Non-GAAP Gross Profit, Non-GAAP Income (Loss) from
Operations and Non-GAAP Net Income (Loss) provide useful
supplemental information to investors and others in understanding
and evaluating our results of operations, as well as provide a
useful measure for period-to-period comparisons of our business
performance.
We define free cash flow as net cash (used in)
provided by operating activities less cash used for purchases of
property and equipment. We believe that free cash flow is a useful
indicator of liquidity that provides information to management and
investors, even if negative, about the amount of cash used in our
operations other than that used for investments in property and
equipment.
Other Business Metrics
Active Customers – we define
Active Customers as customers who have entered into a license
agreement with us that remains in effect. The retention and
expansion of our relationships with existing customers are key
indicators of our revenue potential.
Annual Contract Value (ACV) –
we define Annual Contract Value for an individual customer
agreement as the total fixed fees under the agreement divided by
the number of years in the agreement term. Our total ACV is the
aggregate ACVs for all our customers as measured at a given point
in time. Total fixed fees includes licensing, support and
maintenance and other fixed fees under IP licensing or software
licensing agreements but excludes variable revenue derived from
licensing agreements with customers, particularly royalties.
Confirmed Design Starts – we
define Confirmed Design Starts as when customers confirm their
commencement of new semiconductor designs using our interconnect IP
and notify us. Confirmed Design Starts is a metric management uses
to assess the activity level of our customers in terms of the
number of new semiconductor designs that are started using our
interconnect IP in a given period. We believe that the number of
Confirmed Design Starts is an important indicator of the growth of
our business and future royalty revenue trends.
Remaining Performance Obligations (RPO)
– we define Remaining Performance Obligations as the
amount of contracted future revenue that has not yet been
recognized, including deferred revenue, billed and unbilled
cancelable and non-cancelable contracted amounts.
Arteris, Inc.Reconciliation of GAAP
Measures to Non-GAAP Measures(In thousands, except share
and per share data)(Unaudited) |
|
|
Three Months Ended December
31, |
|
Twelve Months Ended December
31, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Gross profit |
$ |
11,056 |
|
|
$ |
10,118 |
|
|
$ |
48,589 |
|
|
$ |
46,097 |
|
Add: |
|
|
|
|
|
|
|
Stock-based compensation expense included in cost of revenue |
|
170 |
|
|
|
88 |
|
|
|
556 |
|
|
|
562 |
|
Amortization of acquired intangible assets (1) |
|
50 |
|
|
|
— |
|
|
|
149 |
|
|
|
— |
|
Non-GAAP gross profit |
$ |
11,276 |
|
|
$ |
10,206 |
|
|
$ |
49,294 |
|
|
$ |
46,659 |
|
Gross margin |
|
88 |
% |
|
|
90 |
% |
|
|
91 |
% |
|
|
92 |
% |
Non-GAAP gross margin |
|
90 |
% |
|
|
91 |
% |
|
|
92 |
% |
|
|
93 |
% |
|
|
|
|
|
|
|
|
Research and development |
$ |
10,663 |
|
|
$ |
10,318 |
|
|
$ |
45,128 |
|
|
$ |
41,167 |
|
Stock-based compensation expense |
|
(1,668 |
) |
|
|
(1,430 |
) |
|
|
(7,324 |
) |
|
|
(5,865 |
) |
Amortization of acquired intangible assets (1) |
|
(85 |
) |
|
|
(85 |
) |
|
|
(390 |
) |
|
|
(340 |
) |
Non-GAAP research and development |
$ |
8,910 |
|
|
$ |
8,803 |
|
|
$ |
37,414 |
|
|
$ |
34,962 |
|
|
|
|
|
|
|
|
|
Sales and marketing |
$ |
5,029 |
|
|
$ |
4,631 |
|
|
$ |
20,659 |
|
|
$ |
17,419 |
|
Stock-based compensation expense |
|
(624 |
) |
|
|
(445 |
) |
|
|
(2,712 |
) |
|
|
(2,123 |
) |
Amortization of acquired intangible assets (1) |
|
(57 |
) |
|
|
(35 |
) |
|
|
(228 |
) |
|
|
(138 |
) |
Non-GAAP sales and marketing |
$ |
4,348 |
|
|
$ |
4,151 |
|
|
$ |
17,719 |
|
|
$ |
15,158 |
|
|
|
|
|
|
|
|
|
General and administrative |
$ |
4,613 |
|
|
$ |
4,229 |
|
|
$ |
17,944 |
|
|
$ |
16,367 |
|
Stock-based compensation expense |
|
(1,092 |
) |
|
|
(647 |
) |
|
|
(3,943 |
) |
|
|
(3,142 |
) |
Acquisition costs (2) |
|
— |
|
|
|
(527 |
) |
|
|
— |
|
|
|
(527 |
) |
Non-GAAP general and administrative |
$ |
3,521 |
|
|
$ |
3,055 |
|
|
$ |
14,001 |
|
|
$ |
12,698 |
|
|
|
|
|
|
|
|
|
Loss from operations |
$ |
(9,249 |
) |
|
$ |
(9,060 |
) |
|
$ |
(35,142 |
) |
|
$ |
(28,856 |
) |
Stock-based compensation expense |
|
3,554 |
|
|
|
2,610 |
|
|
|
14,535 |
|
|
|
11,692 |
|
Acquisition costs (2) |
|
— |
|
|
|
527 |
|
|
|
— |
|
|
|
527 |
|
Amortization of acquired intangible assets (1) |
|
192 |
|
|
|
120 |
|
|
|
767 |
|
|
|
478 |
|
Non-GAAP loss from operations |
$ |
(5,503 |
) |
|
$ |
(5,803 |
) |
|
$ |
(19,840 |
) |
|
$ |
(16,159 |
) |
|
|
|
|
|
|
|
|
Net loss |
$ |
(10,541 |
) |
|
$ |
(7,215 |
) |
|
$ |
(36,869 |
) |
|
$ |
(27,387 |
) |
Stock-based compensation expense |
|
3,554 |
|
|
|
2,610 |
|
|
|
14,535 |
|
|
|
11,692 |
|
Acquisition costs (2) |
|
— |
|
|
|
527 |
|
|
|
— |
|
|
|
527 |
|
Amortization of acquired intangible assets (1) |
|
192 |
|
|
|
120 |
|
|
|
767 |
|
|
|
478 |
|
Non-GAAP net loss (3) |
$ |
(6,795 |
) |
|
$ |
(3,958 |
) |
|
$ |
(21,567 |
) |
|
$ |
(14,690 |
) |
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders, basic and
diluted |
$ |
(0.29 |
) |
|
$ |
(0.21 |
) |
|
$ |
(1.03 |
) |
|
$ |
(0.84 |
) |
Per share impacts of adjustments to net loss (4) |
$ |
0.11 |
|
|
$ |
0.09 |
|
|
$ |
0.43 |
|
|
$ |
0.39 |
|
Non-GAAP net loss per share attributable to common stockholders,
basic and diluted |
$ |
(0.18 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.60 |
) |
|
$ |
(0.45 |
) |
|
|
|
|
|
|
|
|
Weighted average shares used in computing per share amounts, basic
and diluted |
|
36,816,597 |
|
|
|
33,596,146 |
|
|
|
35,675,689 |
|
|
|
32,578,776 |
|
(1) Represents the amortization expenses of our
intangible assets attributable to our acquisitions.(2) Includes
advisory, legal, accounting, valuation, and other professional or
consulting fees associated with the Magillem and Semifore
acquisitions and recorded in general and administrative. (3) Our
GAAP tax provision is primarily related to foreign withholding
taxes and income tax in profitable foreign jurisdictions. We
maintain a full valuation allowance against our deferred tax assets
in the US. Accordingly, there is no significant tax impact
associated with these Non-GAAP adjustments.(4) Reflects the
aggregate adjustments made to reconcile Non-GAAP Net Loss to our
net loss as noted in the above table, divided by the GAAP diluted
weighted average number of shares of the relevant period.
Free Cash Flow
|
|
Twelve Months Ended December 31, |
|
|
|
2023 |
|
|
|
2022 |
|
Net cash used in operating activities |
|
$ |
(15,729 |
) |
|
$ |
(6,767 |
) |
Less: |
|
|
|
|
Purchase of property and equipment |
|
|
(1,503 |
) |
|
|
(1,051 |
) |
Free cash flow |
|
$ |
(17,232 |
) |
|
$ |
(7,818 |
) |
Net cash used in investing activities |
|
$ |
(4,691 |
) |
|
$ |
(37,481 |
) |
Net cash used in financing activities |
|
$ |
(2,919 |
) |
|
$ |
(4,154 |
) |
Arteris (NASDAQ:AIP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arteris (NASDAQ:AIP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024